chr5-56111553-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024669.3(ANKRD55):c.1195G>A(p.Asp399Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024669.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKRD55 | NM_024669.3 | c.1195G>A | p.Asp399Asn | missense_variant | 10/12 | ENST00000341048.9 | |
ANKRD55 | XM_047417710.1 | c.709G>A | p.Asp237Asn | missense_variant | 6/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKRD55 | ENST00000341048.9 | c.1195G>A | p.Asp399Asn | missense_variant | 10/12 | 2 | NM_024669.3 | P1 | |
ANKRD55 | ENST00000434982.2 | c.331G>A | p.Asp111Asn | missense_variant | 2/4 | 1 | |||
ANKRD55 | ENST00000504958.6 | c.1066G>A | p.Asp356Asn | missense_variant | 8/10 | 5 | |||
ANKRD55 | ENST00000505970.2 | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152188Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250282Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135312
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460820Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 726746
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 10, 2023 | The c.1195G>A (p.D399N) alteration is located in exon 10 (coding exon 9) of the ANKRD55 gene. This alteration results from a G to A substitution at nucleotide position 1195, causing the aspartic acid (D) at amino acid position 399 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at